---
title: "FibroBiologics, Inc. (FBLG.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/FBLG.US.md"
symbol: "FBLG.US"
name: "FibroBiologics, Inc."
industry: "Biotechnology"
datetime: "2026-05-20T12:37:45.775Z"
locales:
  - [en](https://longbridge.com/en/quote/FBLG.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/FBLG.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/FBLG.US.md)
---

# FibroBiologics, Inc. (FBLG.US)

## Company Overview

FibroBiologics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases. The company’s product pipeline includes CYWC628 which has completed pre-clinical trial for the treatment of wound healing; CYMS101 which has completed Phase 1 trial for the treatment of multiple sclerosis; CybroCell for the treatment of degenerative disc disease; and CYPS317 for the treatment of psoriasis. It also develops early-stage research products, including CYTER915 to treat the human longevity; and TCB190 for the treatment of certain cancers. FibroBiologics, Inc.

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Exchange | US Market |
| Website | [fibrobiologics.com](https://fibrobiologics.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.26 | 101 | - | - | - |
| PB | 1.89 | 178 | 132.24 | 23.89 | 3.74 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-04T04:00:00.000Z

Total Analysts: **4**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 1 | 25% |
| Hold | 2 | 50% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 1.08 |
| Highest Target | 19.00 |
| Lowest Target | 8.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/FBLG.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/FBLG.US/norm.md)
- [Related News](https://longbridge.com/en/quote/FBLG.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/FBLG.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**